Tommaso Clemente

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Editorial Comment

Human Immunodeficiency Virus

Circulating Tumor

Top Venues

Annals of clinical microbiology and antimicrobials

The Journal of antimicrobial chemotherapy

JAC-antimicrobial resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Camilla Muccini, Nicola Gianotti, Sara Diotallevi, Riccardo Lolatto, Vincenzo Spagnuolo, Diana Canetti, Sabrina Bagaglio, Victoria Gordo Perez, Tommaso Clemente, Martina Bottanelli, Caterina Candela, Silvia Nozza, Antonella Castagna
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study. Open forum infectious diseases 11 (7) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Daniele Armenia, Vincenzo Spagnuolo, Maria C Bellocchi, Laura Galli, Leonardo Duca, Greta Marchegiani, Tommaso Clemente, Luca Carioti, Riccardo Lolatto, Leonardo Calza, Benedetto M Celesia, Antonio Cascio, Daniela Francisci, Annalisa Saracino, Carlo Torti, Maurizio Zazzi, Antonella Castagna, Maria-Mercedes Santoro, null null
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry. The Journal of antimicrobial chemotherapy (2024)
Daniele Armenia, Vincenzo Spagnuolo, Maria C Bellocchi, Laura Galli, Leonardo Duca, Greta Marchegiani, Tommaso Clemente, Luca Carioti, Riccardo Lolatto, Leonardo Calza, Benedetto M Celesia, Antonio Cascio, Daniela Francisci, Annalisa Saracino, Carlo Torti, Maurizio Zazzi, Antonella Castagna, Maria-Mercedes Santoro, null null
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Tommaso Clemente, Diana Canetti, Emanuela Messina, Elisabetta Carini, Liviana Della Torre, Rebecka Papaioannu Borjesson, Antonella Castagna, Vincenzo Spagnuolo
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. JAC-antimicrobial resistance 6 (3) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Tommaso Clemente, Diana Canetti, Emanuela Messina, Elisabetta Carini, Liviana Della Torre, Rebecka Papaioannu Borjesson, Antonella Castagna, Vincenzo Spagnuolo
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. JAC-antimicrobial resistance 6 (3) (2024)
Mazzitelli Maria, Domenico Pontillo, Tommaso Clemente, Antonio Di Biagio, Giovanni Cenderello, Stefano Rusconi, Barbara Menzaghi, Chiara Fornabaio, Elisa Garlassi, Maurizio Zazzi, Antonella Castagna, Anna Maria Cattelan, null null
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Camilla Muccini, Nicola Gianotti, Sara Diotallevi, Riccardo Lolatto, Vincenzo Spagnuolo, Diana Canetti, Sabrina Bagaglio, Victoria Gordo Perez, Tommaso Clemente, Martina Bottanelli, Caterina Candela, Silvia Nozza, Antonella Castagna
One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART Study. Open forum infectious diseases 11 (7) (2024)
Tommaso Clemente, Diana Canetti, Emanuela Messina, Elisabetta Carini, Liviana Della Torre, Rebecka Papaioannu Borjesson, Antonella Castagna, Vincenzo Spagnuolo
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. JAC-antimicrobial resistance 6 (3) (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Mazzitelli Maria, Domenico Pontillo, Tommaso Clemente, Antonio Di Biagio, Giovanni Cenderello, Stefano Rusconi, Barbara Menzaghi, Chiara Fornabaio, Elisa Garlassi, Maurizio Zazzi, Antonella Castagna, Anna Maria Cattelan, null null
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry. The Journal of antimicrobial chemotherapy (2024)
Tommaso Clemente, Laura Galli, Riccardo Lolatto, Roberta Gagliardini, Filippo Lagi, Micol Ferrara, Anna Maria Cattelan, Emanuele Foca', Antonio Di Biagio, Adriana Cervo, Leonardo Calza, Franco Maggiolo, Giulia Carla Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria-Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna, null null
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ open 14 (2) (2024)
Tommaso Clemente, Diana Canetti, Emanuela Messina, Elisabetta Carini, Liviana Della Torre, Rebecka Papaioannu Borjesson, Antonella Castagna, Vincenzo Spagnuolo
Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. JAC-antimicrobial resistance 6 (3) (2024)
Tommaso Clemente, Diana Canetti, Lorenzo Dagna, Caterina Uberti Foppa, Antonella Castagna, Vincenzo Spagnuolo, Silvia Nozza, Corrado Campochiaro
Monkeypox in a patient with undifferentiated connective tissue disease. Rheumatology (Oxford, England) (2022)
Tommaso Clemente, Vincenzo Spagnuolo, Martina Bottanelli, Marco Ripa, Benedetto Del Forno, Elena Busnardo, Giuseppe Di Lucca, Antonella Castagna, Anna Danise
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi's sarcoma: a case report. Annals of clinical microbiology and antimicrobials 21 (1) (2022)
Tommaso Clemente, Vincenzo Spagnuolo, Martina Bottanelli, Marco Ripa, Benedetto Del Forno, Elena Busnardo, Giuseppe Di Lucca, Antonella Castagna, Anna Danise
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi's sarcoma: a case report. Annals of clinical microbiology and antimicrobials 21 (1) (2022)
Tommaso Clemente, Vincenzo Spagnuolo, Martina Bottanelli, Marco Ripa, Benedetto Del Forno, Elena Busnardo, Giuseppe Di Lucca, Antonella Castagna, Anna Danise
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi's sarcoma: a case report. Annals of clinical microbiology and antimicrobials 21 (1) (2022)
Tommaso Clemente, Vincenzo Spagnuolo, Martina Bottanelli, Marco Ripa, Benedetto Del Forno, Elena Busnardo, Giuseppe Di Lucca, Antonella Castagna, Anna Danise
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi's sarcoma: a case report. Annals of clinical microbiology and antimicrobials 21 (1) (2022)